Plasma 3-epi-25-hydroxycholecalciferol can alter the assessment of vitamin D status using the current reference ranges for pregnant women and their newborns

Journal of Nutrition

Volumn 146, Issue 1, 2016, Pages 70-75

  Aghajafari, Fariba ^a   Field, Catherine J ^b   Rabi, Doreen ^a   Kaplan, Bonnie J ^a   Maggiore, Jack A ^c   Beirne, Maeve O ^a   Hanley, David A ^a   Eliasziw, Misha ^d   Dewey, Deborah ^a   Ross, Sue ^b  

^a UNIVERSITY OF CALGARY   (Canada)

^b UNIVERSITY OF ALBERTA   (Canada)

^c Doctor's Data Inc   (United States)

^d TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

25(OH)D; 3 epi 25(OH)D3; Cord blood; LC MS MS; Pregnancy

Indexed keywords

3 EPI 25 HYDROXYCHOLECALCIFEROL; CALCIFEDIOL; UNCLASSIFIED DRUG; VITAMIN D;

ADULT; ARTICLE; COHORT ANALYSIS; FEMALE; HUMAN; LONGITUDINAL STUDY; MATERNAL BLOOD; NEWBORN; PREGNANT WOMAN; PREVALENCE; UMBILICAL CORD BLOOD; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY; VITAMIN SUPPLEMENTATION; BLOOD; CANADA; CHEMISTRY; DIETARY SUPPLEMENT; FETUS BLOOD; LIQUID CHROMATOGRAPHY; MATERNAL NUTRITION; MIDDLE AGED; PREGNANCY; REFERENCE VALUE; SOCIOECONOMICS; STATISTICAL MODEL; TANDEM MASS SPECTROMETRY; YOUNG ADULT;

ADULT; CALCIFEDIOL; CANADA; CHROMATOGRAPHY, LIQUID; DIETARY SUPPLEMENTS; FEMALE; FETAL BLOOD; HUMANS; INFANT, NEWBORN; LINEAR MODELS; LONGITUDINAL STUDIES; MATERNAL NUTRITIONAL PHYSIOLOGICAL PHENOMENA; MIDDLE AGED; PREGNANCY; PREVALENCE; REFERENCE VALUES; SOCIOECONOMIC FACTORS; TANDEM MASS SPECTROMETRY; VITAMIN D; VITAMIN D DEFICIENCY; YOUNG ADULT;

EID: 84959284078     PISSN: 00223166     EISSN: 15416100     Source Type: Journal    
DOI: 10.3945/jn.115.220095     Document Type: Article

References (18)

1. Aghajafari F, Nagulesapillai T, Ronksley PE, Tough SC, O'Beirne M, Rabi D. Association between maternal serum 25-hydroxyvitamin D level and pregnancy and neonatal outcomes: systematic review and meta-analysis of observational studies. BMJ 2013;346:f1169.
2. Holick MF. Vitamin D deficiency. N Engl J Med 2007;357:266-81.
3. Health Canada. Vitamin D and calcium: updated Dietary Reference Intakes. [cited 2012 Mar 22]. Available from: http://www.hc-sc.gc.ca/fn-an/nutrition/vitamin/vita-d-eng.php.
4. Institute of Medicine. Dietary Reference Intakes for calcium and vitamin D. Washington (DC): National Academies Press; 2011.
5. Bailey D, Veljkovic K, Yazdanpanah M, Adeli K. Analytical measurement and clinical relevance of vitamin D(3) C3-epimer. Clin Biochem 2013;46:190-6.
6. Karras SN, Shah I, Petroczi A, Goulis DG, Bili H, Papadopoulou F, Harizopoulou V, Tarlatzis BC, Naughton DP. An observational study reveals that neonatal vitamin D is primarily determined by maternal contribution: implications of a new assay on the roles of vitamin D forms. Nutr J 2013;7;12:77.
7. Bailey D, Perumal N, YazdanpanahM, AlMahmud A, Baqui AH, Adeli K, Roth D. Maternal-fetal-infant dynamic of C3 epimer of 25-hydroxy vitamin D. Clin Biochem 2014;47:816-22.
8. van den Ouweland JM, Beijers AM, Demacker PN, van Daal H. Measurement of 25-OH- vitamin D in human serum using liquid chromatography tandem-mass spectrometry with comparison to radioimmunoassay and automated immunoassay. J Chromatogr B Analyt Technol Biomed Life Sci 2010;878:1163-8.
9. Kaplan BJ, Giesbrecht GF, Leung BM, Field CJ, Dewey D, Bell RC, Manca D, O'Beirne M, Johnston DW, Pop VJ, et al. The Alberta Outcomes and Nutrition (APrON) cohort study: rationale and methods. Matern Child Nutr 2014;10:44-60.
10. Holick MF. High prevalence of vitamin D inadequacy and implications for health. Mayo Clin Proc 2006;81:353-73.
11. Fitzpatrick TB. The validity and practicality of sun-reactive skin types I through VI. Arch Dermatol 1988;124:869-71.
12. Massey DS, Charles CZ, Lundy G, Fischer MJ. The source of the river: the social origins of freshmen at America's selective colleges and universities. Princeton (NJ): Princeton University Press; 2003.
13. Hanley DA, Cranney A, Jones G, Whiting SJ, Leslie WD, Cole DE, Atkinson SA, Josse RG, Feldman S, Kline GA, et al; Guidelines Committee of the Scientific Advisory Council of Osteoporosis Canada. Vitamin D in adult health and disease: a review and guideline statement from Osteoporosis Canada. CMAJ 2010;182:E610-8.
14. Holick MF, Binkley NC, Bischoff-Ferrari HA, Gordon CM, Hanley DA, Heaney RP, Murad MH, Weaver CM; Endocrine Society. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 2011;96:1911-30.
15. Gómez MF, Field CJ, Olstad DL, Loehr S, Ramage S, McCargar LJ; APrON Study Team. Use of micronutrient supplements among pregnant women in Alberta: results from the Alberta Pregnancy Outcomes and Nutrition (APrON) cohort. Matern Child Nutr 2015;11:497-510.
16. Kamao M, Tatematsu S, Hatakeyama T, Sakaki N, Sawada K, Inouye K, Ozono K, Kubodera N, Reddy GS, Okano T. C-3 epimerization of vitamin D3 metabolites and further metabolism of C-3epimers:25-hydroxyvitamin D3 is metabolized to 3-epi-25-hydroxyvitamin D3 and subsequently metabolized through C-1alpha or C-24 hydroxylation. J Biol Chem 2004;279:15897-907.
17. Morrison NA, Eisman JA. Nonhypercalcemic 1,25-(OH)2D3 analogs potently induce the human osteocalcin gene promoter stably transfected into rat osteosarcoma cells (ROSCO-2). J BoneMiner Res 1991;6:893-9.
18. Cashman KD, Kinsella M, Walton J, Flynn A, Hayes A, Lucey AJ, Seamans KM, Kiely M. The 3 epimer of 25-hydroxycholecalciferol is present in the circulation of the majority of adults in a nationally representative sample and has endogenous origins. J Nutr 2014;144:1050-7.